EUVIMEDEUVIMED entdecken
Crossref

Preclinical Pharmacokinetics in Tumors and Normal Tissues of the Antigene PNA Oligonucleotide MYCN-Inhibitor BGA002

Anna Lisa Scardovi, Damiano Bartolucci iD, Luca Montemurro iD, Sonia Bortolotti iD, Silvia Angelucci, Camilla Amadesi, Giammario Nieddu, Sean Oosterholt, Lucia Cerisoli, Oscar Della Pasqua, Patrizia Hrelia, Roberto Tonelli iD

Nucleic Acid Therapeutics · 2024

DOI: 10.1089/nat.2024.0005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2024. Verfasst von Anna Lisa Scardovi und 11 weiteren Autor:innen. Beteiligte Einrichtung: R&D Department, BIOGENERA SpA, Bologna, Italy. Hauptthemen laut MEDLINE: N-Myc Proto-Oncogene Protein, Peptide Nucleic Acids, Neuroblastoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Myc Proto-Oncogene ProteinPeptide Nucleic AcidsNeuroblastomaAnimalsMiceFemaleHumansMaleTissue DistributionCell Line, TumorRhabdomyosarcomaNuclear ProteinsOrganic Chemicals

Stichwörter der Autor:innen

MYCN-positive tumorsantigene PNA-peptidebiodistributionpharmacodynamicspharmacokinetics

Substanzen

N-Myc Proto-Oncogene ProteinPeptide Nucleic AcidsMYCN protein, humanNuclear ProteinsMYCN inhibitor BGA002Organic Chemicals

Autor:innen und Institutionen

  • R&D Department, BIOGENERA SpA, Bologna, Italy.
  • AGEOP Ricerca OdV, IRCCS S. Orsola Hospital, Pediatric Oncology and Hematology Unit, Bologna, Italy.
  • Clinical Pharmacology & Therapeutics Group, University College London, London, United Kingdom.
  • Department of Pharmacy and Biotechnologies, University of Bologna, Bologna, Italy.

ORCID-Profile: Damiano Bartolucci, Luca Montemurro, Sonia Bortolotti, Roberto Tonelli

Zitieren

APA

Scardovi, A. L., Bartolucci, D., Montemurro, L., Bortolotti, S., Angelucci, S., Amadesi, C., Nieddu, G., Oosterholt, S., Cerisoli, L., Della Pasqua, O., Hrelia, P., & Tonelli, R. (2024). Preclinical Pharmacokinetics in Tumors and Normal Tissues of the Antigene PNA Oligonucleotide MYCN-Inhibitor BGA002. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2024.0005

Vancouver

Scardovi AL, Bartolucci D, Montemurro L, Bortolotti S, Angelucci S, Amadesi C, et al. Preclinical Pharmacokinetics in Tumors and Normal Tissues of the Antigene PNA Oligonucleotide MYCN-Inhibitor BGA002. Nucleic Acid Therapeutics. 2024. doi:10.1089/nat.2024.0005

BibTeX
@article{Scardovi2024,
  author = {Scardovi, Anna Lisa and Bartolucci, Damiano and Montemurro, Luca and Bortolotti, Sonia and Angelucci, Silvia and Amadesi, Camilla and Nieddu, Giammario and Oosterholt, Sean and Cerisoli, Lucia and Della Pasqua, Oscar and Hrelia, Patrizia and Tonelli, Roberto},
  title = {Preclinical Pharmacokinetics in Tumors and Normal Tissues of the Antigene PNA Oligonucleotide MYCN-Inhibitor BGA002},
  journal = {Nucleic Acid Therapeutics},
  year = {2024},
  doi = {10.1089/nat.2024.0005}
}
Kostenlos starten →